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background: Candidates for primary prevention implantable cardioverter-defibrillator (ICD) are identified primarily based on left ventricular 
ejection fraction (LVEF) determined by echocardiography (echo). It is unclear how the increasing use of cardiac magnetic resonance imaging (CMR) 
will affect patient candidacy for primary prevention ICD, especially among patients with LVEF near the cutoff for ICD implantation.
methods: Patients undergoing CMR at our institution in the last 2 years, with echo done within 1 year of CMR, were identified. Those with 
myocardial infarction, revascularization, cardioversion, or acute decompensated heart failure within 90 days of or between studies were excluded 
(n=418). Separate analysis was performed for patients with LVEF of 25-40% by echo (n=74).
results: Echo preceded CMR in 77% of patients, with a median (interquartile range) difference of 9 (2-45) days. Mean LVEF was higher by CMR 
than by echo (54% vs 49%, p < 0.001). In patients with LVEF 25-40% by echo, mean LVEF was also higher by CMR (38% vs 31%, p < 0.001), and 
there was poor inter-study agreement on ICD candidacy. 27% of these patients had LVEF 35% by CMR.
conclusion: Although CMR is a useful tool for anatomic and functional cardiac assessment, LVEF derived by CMR is higher than that by echo. 
Clinicians should be aware of this difference in LVEF when considering patient candidacy for primary prevention ICD, especially in patients with LVEF 
near the 30% or 35% cutoff.
All subjects (n=418) LVEF 25-40% (n=74)
Echo LVEF
Mean (SD)
48.9 (15.6) 31.1 (4.6)
CMR LVEF
Mean (SD)
53.6 (16.3) 37.8 (10.1)
Echo vs CMR p-value
(paired T-test)
< 0.001 < 0.001
Echo/CMR agreement <30% 94.5% 81.1%
Echo/CMR agreement <35% 92.1% 67.6%
